Bookbuilding IPO | ₹846 Cr | Listed at BSE, NSE | Fri, Nov 29, 2024 - Tue, Dec 3, 2024
Suraksha Diagnostic IPO is a book build issue of ₹846.25 crores. The issue is entirely an offer for sale of 1.92 crore shares of ₹846.25 crore.
Suraksha Diagnostic IPO bidding started from Nov 29, 2024 and ended on Dec 3, 2024. The allotment for Suraksha Diagnostic IPO was finalized on Dec 4, 2024. The shares got listed on BSE, NSE on Dec 6, 2024.
Suraksha Diagnostic IPO price band is set at ₹441 per share. The lot size for an application is 34. The minimum amount of investment required by an retail is ₹14,994 (34 shares) (based on upper price). The lot size investment for sNII is 14 lots (476 shares), amounting to ₹2,09,916, and for bNII, it is 67 lots (2,278 shares), amounting to ₹10,04,598.
ICICI Securities Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Suraksha Diagnostic IPO RHP for detailed Information.
IPO Open
Fri, Nov 29, 2024
IPO Close
Tue, Dec 3, 2024
Issue Price
₹441 per share
Market Cap (Pre-IPO)
₹2,296.76 Cr
| IPO Date | 29 Nov to 3 Dec, 2024 |
| Listed on | Fri, Dec 6, 2024 |
| Face Value | ₹2 per share |
| Price Band | ₹420 to ₹441 |
| Issue Price | ₹441 per share |
| Lot Size | 34 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,91,89,330 shares (agg. up to ₹846 Cr) |
| Offer for Sale | 1,91,89,330 shares of ₹2 (agg. up to ₹846 Cr) |
| Share Holding Pre Issue | 5,20,80,758 shares |
| Share Holding Post Issue | 5,20,80,758 shares |
| BSE Script Code / NSE Symbol | 544293 / SURAKSHA |
| ISIN | INE877V01027 |
Suraksha Diagnostic IPO offers total 1,91,89,330 shares. Out of which 95,94,664 (50.00%) allocated to QIB, 38,37,867 (20.00%) allocated to QIB (Ex- Anchor), 28,78,400 (15.00%) allocated to NII 67,16,266 (35.00%) allocated to RII and 57,56,797 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 95,94,664 (50.00%) | NA |
| − Anchor Investor Shares Offered | 57,56,797 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 38,37,867 (20.00%) | NA |
| NII (HNI) Shares Offered | 28,78,400 (15.00%) | NA |
| − bNII > ₹10L | 19,18,934 (10.00%) | 4,031 |
| − sNII < ₹10L | 9,59,466 (5.00%) | 2,015 |
| Retail Shares Offered | 67,16,266 (35.00%) | 1,97,537 |
| Total Shares Offered | 1,91,89,330 (100.00%) |
Investors can bid for a minimum of 34 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹1,94,922 |
| S-HNI (Min) | 14 | 476 | ₹2,09,916 |
| S-HNI (Max) | 66 | 2,244 | ₹9,89,604 |
| B-HNI (Min) | 67 | 2,278 | ₹10,04,598 |
Suraksha Diagnostic IPO raises ₹253.87 crore from anchor investors. Suraksha Diagnostic IPO Anchor bid date is November 28, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Thu, Nov 28, 2024 |
| Shares Offered | 57,56,797 |
| Anchor Portion (₹ Cr.) | 253.87 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, Jan 3, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Mar 4, 2025 |
Incorporated in 2005, Suraksha Diagnostic Limited offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya.
The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors.
The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System ("LIMS"), its fully integrated Radiology Information System ("RIS"), its Picture Archive Communication System ("PACS") and its Enterprise Resource Planning System ("ERP").
The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time.
Competitive Strengths are:
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Total Income | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| NET Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | The Company will not receive any proceeds from the Offer (“Offer Proceeds”) and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders. |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 14.09% |
| ROCE | 21.46% |
| Debt/Equity | 0.20 |
| RoNW | 14.09% |
| PAT Margin | 10.57% |
| Price to Book Value | 13.10 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 4.44 | 5.89 |
| P/E (x) | 99.31 | 74.89 |
| Promoter Holding | 61.07% | 48.78% |
| Market Cap | ₹2,296.76 Cr. |
The Suraksha Diagnostic IPO is subscribed 1.27 times on December 3, 2024 6:19:07 PM (Day 3). The public issue subscribed 0.94 times in the retail category, 1.74 times in the QIB category, and 1.4 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 1.74 | 38,37,867 | 66,67,332 |
| NII | 1.4 | 28,78,400 | 40,42,124 |
| bNII (bids above ₹10L) | 1.53 | 19,18,934 | 29,29,950 |
| sNII (bids below ₹10L) | 1.16 | 9,59,466 | 11,12,174 |
| Retail | 0.94 | 67,16,266 | 62,99,078 |
| Total | 1.27 | 1,34,32,533 | 1,70,08,534 |
Total Application : 1,47,938
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLMs fees and commissions (including underwriting commission) | 24.96 |
| 2 | Brokerage, selling commission, bidding charges, processing fees and bidding charges for the Members of the Syndicate, Registered Brokers, SCSBs, RTAs and CDPs | 2.35 |
| 3 | Advertising and marketing expenses for the Offer | 4.76 |
| 4 | Other expenses: Listing fees, SEBI filing fees, BSE & NSE processing fees, book building software fees | 3.17 |
| 5 | Other regulatory expenses, | 0.02 |
| 6 | Printing and stationery expenses | 2.05 |
| 7 | Fees payable to the Registrar to the Offer | 0.56 |
| 8 | Fees payable to the legal counsel | 4.30 |
| 9 | Miscellaneous | 5.34 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹441.00 | ₹441.00 |
| Open | ₹437.00 | ₹438.00 |
| Low | ₹414.80 | ₹414.95 |
| High | ₹449.00 | ₹449.00 |
| Last Trade | ₹417.95 | ₹441.00 |
Suraksha Diagnostic IPO is a main-board IPO of 1,91,89,330 equity shares of the face value of ₹2 aggregating up to ₹846 Crores. The issue is priced at ₹441 per share. The minimum order quantity is 34.
The IPO opens on Fri, Nov 29, 2024, and closes on Tue, Dec 3, 2024.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Suraksha Diagnostic IPO using UPI as a payment gateway. Zerodha customers can apply in Suraksha Diagnostic IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Suraksha Diagnostic IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Suraksha Diagnostic IPO opens on Fri, Nov 29, 2024 and closes on Tue, Dec 3, 2024.
Suraksha Diagnostic IPO lot size is 34, and the minimum amount required for application is ₹14,994.
You can apply in Suraksha Diagnostic IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Suraksha Diagnostic IPO will be done on Wednesday, December 4, 2024, and the allotted shares will be credited to your demat account by Thu, Dec 5, 2024. Check the Suraksha Diagnostic IPO allotment status.
The Suraksha Diagnostic IPO listing date is on Fri, Dec 6, 2024.
